A 45-year-old man without major coronary risk factors, including hypertension, diabetes mellitus, smoking, hypercholesterolemia, hyperuricemia, or a family history of early cardiovascular disease, presented with acute coronary syndrome. Angiography showed thrombus formation in segment 7 of the left anterior descending coronary artery, and percutaneous coronary intervention was successful after implantation of a bare metal stent. Scintigraphy showed the absence of 123 I--methyl-iodophenyl pentadecanoic acid accumulation in the myocardium. Flow cytometric analysis of platelets and monocytes showed the absence of cluster differentiation (CD)-36 expression. These findings are consistent with a diagnosis of CD36 deficiency type 1, which might be associated with cardiovascular disease. The patient had no apparent major coronary risk factors except for insulin resistance and an abnormal lipoprotein profile. The findings suggest that in this case the CD36 deficiency type 1 was the pathogenic mechanism of acute coronary syndrome relative to insulin resistance and modification of the lipid profile. (Circ J 2007; 71: 166 -169) 
luster differentiation (CD)-36 was identified over 25 years ago as a platelet integral membrane glycoprotein (glycoprotein IV) that functions as a receptor for thrombospondin, collagen, and oxidized low-density lipoprotein (LDL) in platelets and as a long-chain fatty acid (LCFA) transporter in several types of cells. 1 Further studies have indicated that a CD36 deficiency is associated with the development of cardiomyopathy, ischemic heart disease, and valvular disease. [2] [3] [4] The present report describes a patient with a CD36 deficiency and with no major coronary risk factors who later developed acute coronary syndrome (ACS).
Case Report
A 45-year-old man was admitted to hospital with severe chest pain in December 2004. For 2 weeks before admission, he had frequently experienced mild chest oppression when cycling to work. He had no major coronary risk factors such as hypertension, hypercholesterolemia, diabetes mellitus, hyperuricemia, smoking, or a family history of early cardiovascular disease. The patient was 168 cm tall and weighed 61 kg (body mass index: 21.6 kg/m 2 ), with blood pressure of 112/56 mmHg and a regular pulse of 58 beats/min. Mild coarse crackles were evident in both lung fields, but heart sounds were normal. Twelve-lead electrocardiography showed ST-segment elevation in leads V1-3 and inverted T-waves in leads V1-4 (Fig 1) . Echocardiography showed reduced motion in the antero-septal wall. Blood biochemistry showed increased creatine kinase, myocardial-bound creatine kinase, troponin I, myoglobin and aspartate aminotransferase, but a normal lipid profile and blood sugar level (Table 1) . Bleeding and prothrombin times were also within the normal range (2 min and 10.1 s (international normalized ratio 0.95), respectively).
On the basis of these data, ACS was diagnosed, and emergency coronary angiography showed 90% stenosis with haziness (Thrombolysis In Myocardial Infarction grade 3) at segment 7 of the left anterior descending artery. Other coronary arteries were normal (Fig 2a) . Percutaneous coronary intervention (PCI) was subsequently performed with implantation of a bare metal stent (3.5×12 mm DRIVER ® , Medtronic, Minneapolis, MN, USA) (Fig 2b) . On the second hospital day, ST segment elevation in leads V1-3 and the T-wave inversions in leads V1-4 had resolved.
Myocardial viability was assessed using 201 Tl-Cl and 123 I--methyl-iodophenyl pentadecanoic acid ( 123 I-BMIPP) myocardial scintigraphy on the fifth day after PCI. Scintigraphy showed that 201 Tl-Cl accumulation was normal. By contrast, 123 I-BMIPP did not accumulate in the myocardium (Fig 3) , which was consistent with a myocardial LCFA uptake abnormality (eg, CD36 deficiency). Indeed, subsequent flow cytometric analysis of platelets and monocytes showed the absence of CD36 expression. Thus, a diagnosis of CD36 deficiency type 1 was established. Because CD36 deficiency is an inherited disorder, the patient's parents, 2 sisters, and his 4 children were also assessed. The parents and 2 sisters were normal, but all 4 children of the patient were diagnosed with CD36 deficiency type 2. Table 2 shows the blood biochemical data at the outpatient clinic. The fasting concentration of insulin was 24.6 U/ml and the homeostasis model assessment ratio (HOMA-R) was 8.7, suggesting insulin resistance. Furthermore, the lipoprotein profile on polyacrylamide gel electrophoresis analysis showed 37% high-density lipoprotein (HDL), 42% LDL, 12% very LDL and 9% midband. In contrast, concentrations of other lipids such as total cholesterol, triglyceride (TG), HDL, apo/lipoprotein, remnant-like particles (RLP)-cholesterol, lipoprotein (a), and platelet function including thrombin-antithrombin III complex, plasminogen activator inhibitor 1, thrombomodulin and p-selectin were normal, although the patient had been medicated with calcium channel antagonists, nitrates and antiplatelet agents.
Discussion
CD36 is a multifunctional membrane glycoprotein that is expressed on platelets, monocytes, and endothelial cells. A CD36 deficiency is a hereditary disease that occurs in 0.3-0.5% of Japanese patients with various heart diseases, including cardiomyopathy, ischemic heart disease and valvular disease. 5 CD36 deficiency can be diagnosed via myocardial scintigraphy with BMIPP, an analog of LCFA, in which a CD36 deficiency type 1 (no expression of CD36 on platelets or monocytes) manifests as the complete absence of tracer accumulation in the myocardium and a CD36 deficiency type 2 (positive expression of CD36 on monocytes but not on platelets) manifests as reduced tracer accumulation in the myocardium. 6 The present patient was diagnosed with a CD36 deficiency type 1. The CD36-negative myocardium in patients with this disorder cannot use LCFA as an energy substrate, 7, 8 and such altered myocardial LCFA uptake might play an important role in the pathogenesis of ischemic heart disease.
CD36 might also modulate lipid metabolism, as it acts as a major scavenger receptor for oxidized LDL and as a receptor for HDL. Furthermore, CD36 null-mice have increased plasma TG secondary to decreased lipoprotein lipase (LPL)-mediated hydrolysis of TG-rich lipoproteins in response to induced product inhibition of LPL. 9 YASUNAGA T et al.
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al reported that CD36 regulates the secretion and clearance of intestinal lipoproteins and that a CD36 deficiency results in hypertriglyceridemia in postprandial and fasting states. 10 The lipid profiles of our patient were normal except for the presence of a "midband" in the lipoprotein fraction that indicates RLP, lipoprotein (a) and modified LDL. 11 "Midband lipoproteins" are reportedly related to carotid arteriosclerosis and coronary artery diseases including coronary artery spasm. [12] [13] [14] Although concentrations of RLP and lipoprotein (a) were normal in the present patient, they might represent one cause of ACS. Moreover, a CD36 deficiency is associated with insulin resisitance. 15, 16 An increased fasting insulin concentration and HOMA-R indicated that the patient had insulin resistance. Because insulin resistance is associated with metabolic syndrome, which is linked to atherosclerotic cardiovascular disease, his disorder might be related to ACS. Adiponectin, an adipose-tissue-specific collagen-like protein, is an important antiatherogenic, antidiabetic, and anti-inflammatory protein. 17 Therefore, it is negatively related to metabolic syndrome based on insulin resistance. Indeed, Hong et al showed that the adiponectin concentration in ACS patients is significantly lower than that in those with normal coronary arteries. 18 However, in our case the adiponectin concentration in the present patient was similar to that of patients with normal coronary arteries, which might be because we tested blood samples collected from the patient while he was stabilized with medication.
Further examination is required. An in vitro study has showed that CD36 is necessary for myristic acid-stimulated endothelial nitric-oxide synthesis through adenosine monophosphate kinase but not through the PI-3 kinase/Akt pathway. 19 Because patients with a CD36 deficiency type I do not express CD36 in myocardial capillary endothelial cells, 20 endothelial nitric oxide synthesis might be decreased, thus leading to ACS. Despite differences in the platelet expression of CD36 in patients with this inherited disorder, the relationship between CD36 expression and abnormal platelet function, as well as coagulation, remains unclear. Platelet functions after taking antiplatelet agents, coagulation indices and bleeding time were normal in the present patient at the first emergency event. Thus, the possibility of this patient having had a previous abnormality in platelet functions cannot be denied.
Although Shiraishi et al found from a multicenter study that tobacco smoking, hypercholesterolemia and a family history are the most common risk factors for cardiovascular diseases in young Japanese adults, this 45 year-old patient had neither these nor any other major risk factors, such as diabetes mellitus and hypertension. 21 Parameter Taken together, CD36 deficiency might represent a new risk factor for the development of ACS in association with insulin resistance and modified lipid profiles.
